/PRNewswire/ -- Opportunities in PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and PPAR Agonists What can be expected... ...http://in.advfn.com/p.php?pid=nmona&article=69451708
Posted On: 2015-11-22 21:20:24 Zydus Cadila launches Tenglyn - Teneligliptin 20 mg tablets, which belongs to a new class of oral anti-diabetic... ...http://www.equitybulls.com/admin/news2006/news_det.asp?id=173966
NEW DELHI: Zydus Cadila has received US health regulator's nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high... ...http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-for-clinical-trials-of-sarolitazar/articleshow/49829067.cms
MUMBAI: The health ministry plans to revamp guidelines for approving biosimilar drugs to make the regulatory pathway more robust and sync it with... ...http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/health-ministry-plans-to-revamp-regulatory-rules-for-biosimilar-drugs/articleshow/49823305.cms
DUBLIN , Nov. 03, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hcv3cc/global) has announced the... ...http://in.advfn.com/p.php?pid=nmona&article=69143850
The company was formed way back in...